Eric Benevich, Chief Commercial Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 2,154 shares at $154.61 ($333K) on 2026-09-09, disclosed to the SEC on 2026-09-10.
Scheduled sale ($333k) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| NBIX | SELL | 2025-02-12 | $232K | — | Filing → |
| NBIX | SELL | 2025-02-04 | $369K | — | Filing → |
| NBIX | SELL | 2024-04-17 | $5.3M | — | Filing → |